BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

418 hedge funds and large institutions have $14.8B invested in BioMarin Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 160 increasing their positions, 133 reducing their positions, and 47 closing their positions.

Holders
418
Holders Change
+4
Holders Change %
+0.97%
% of All Funds
10.42%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.22%
New
62
Increased
160
Reduced
133
Closed
47
Calls
$82.3M
Puts
$75.7M
Net Calls
+$6.61M
Net Calls Change
+$11.7M

Top Buyers

1
BlackRock
1
BlackRock
New York
$971M
2
Primecap Management
2
Primecap Management
California
$765M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$852M
4
Jennison Associates
4
Jennison Associates
New York
$869M
5
ClearBridge Investments
5
ClearBridge Investments
New York
$117M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$194M
2
HM
2
HealthCor Management
New York
$0
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$76.9M
4
Victory Capital Management
4
Victory Capital Management
Texas
$81.2M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$1.54M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.72B 19,643,433 +390 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.2B 13,702,404 +495,118 +4%
BlackRock
3
BlackRock
New York
$971M 11,065,452 +10,909,162 +6,980%
Jennison Associates
4
Jennison Associates
New York
$869M 9,894,605 +631,147 +7%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$852M 9,703,010 +812,496 +9%
Sands Capital Management
6
Sands Capital Management
Virginia
$788M 8,972,405 -408,397 -4%
Primecap Management
7
Primecap Management
California
$765M 8,712,268 +826,320 +10%
BBA
8
Baker Bros. Advisors
New York
$422M 4,806,483 – –
State Street
9
State Street
Massachusetts
$351M 4,001,529 +258,417 +7%
Invesco
10
Invesco
Georgia
$319M 3,633,198 +245,430 +7%
Temasek Holdings
11
Temasek Holdings
Singapore
$305M 3,472,712 – –
PAI
12
Palo Alto Investors
California
$209M 2,382,619 +422,400 +22%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$200M 2,279,705 +54,351 +2%
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$194M 2,207,180 -1,030,288 -32%
Wells Fargo
15
Wells Fargo
California
$167M 1,902,717 -375,406 -16%
Bank of America
16
Bank of America
North Carolina
$163M 1,859,874 +172,225 +10%
MNA
17
Manning & Napier Advisors
New York
$149M 1,692,470 -335,460 -17%
O
18
OppenheimerFunds
New York
$147M 1,669,357 -10,020 -0.6%
Franklin Resources
19
Franklin Resources
California
$142M 1,622,057 +480 +0%
Ameriprise
20
Ameriprise
Minnesota
$141M 1,606,441 +31,983 +2%
Goldman Sachs
21
Goldman Sachs
New York
$135M 1,539,459 +158,527 +11%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$131M 1,486,731 +295,308 +25%
TCIM
23
TIAA CREF Investment Management
New York
$121M 1,375,325 +151,663 +12%
ClearBridge Investments
24
ClearBridge Investments
New York
$117M 1,332,958 +516,663 +63%
Deutsche Bank
25
Deutsche Bank
Germany
$117M 1,329,213 -125,349 -9%
1
2 3 4 5